Similarly, the active ingredient of Z. officinale, zingerone, has been shown to inhibit NF-κB activity and downregulate TGF-β expression, further supporting its anti-inflammatory role in DKD (154). The gene discussed is TGFB1; the disease is diabetic kidney disease.